For a better experience of our website please update you web browser from IE11 to Microsoft Edge or an alternative modern browser such as Google Chrome. Thank you.

Category Archives: News

North America is expected to dominate the Phosphoramidite market over the next five years

The Phosphoramidite Market size is estimated at USD 1.13 billion in 2024 and is expected to reach USD 1.79 billion by 2029, growing at a CAGR of 6.42% in the next five years. The factors responsible for the growth of the phosphoramidite market include increasing synthetic nucleotide applications in therapeutics, growth in synthetic biology, and […]

Posted in News |

Primopus looks forward to the year ahead

Progress is being made in the multiple interest areas of our phosphoramidites brand, Amideus. We are fairly unique in having a dedicated team working on phosphoramidites for volume application for CDMO purposes. An increasing area of focus is Fmoc Amino Acids where important news will soon be released. We are meeting the various challenges in […]

Posted in News |

Primopus appreciates art, innovation and impetus

A big thank you to all our clients who attended our booth and our splendid CPHI event at the Picasso/Miro event. The splendid art is an inspiration to all those who appreciate creativity. So it is with our brand Amideus and its focus on phosphoramidites. You cannot simply think today that one region can supply […]

Posted in News |

A CDMO That is Ideally Placed to Meet the Rapidly Changing Pharma Supply Chain Thinking

Driven by a strong geo-political de-risking of overly dependent supply chain arrangements, a drastic rethinking about searching for and developing alternative options is underway in the pharma industry. This is evidenced by several leading companies defining new policies and the separation of activities from select countries. Primopus has been working diligently to repurpose the pharma […]

Posted in News |

Introducing Amideus™, our new Phosphoramidites brand for the Oligonucleotides market

Primopus reaches its first milestone towards becoming one of the largest phosphoramidites manufacturers in the world with Amideus. Marcel Velterop, Primopus CEO, says “the idea of producing bulk Phosporamidites emerged from a best-of-both-worlds strategy that combines our Swiss installed capacity of up to 250m3 with the massive capacity and broad chemistry base of our parent Deccan […]

Posted in News |

Primopus welcomes 7 new colleagues as part of its CDMO expansion plans in Switzerland

Primopus welcomes 7 new colleagues as part of its CDMO expansion plans in Switzerland and wishes everybody a happy, healthy 2023. During 2023 we expect our team to double in size as we start-up our new pilot plant during Q1 and commercial plant by Q4.

Posted in News |

Season’s Greetings to all

As we enter into this festive period, we would like to take this opportunity to wish all of our customers, friends and family all the best for 2023. 2022 has seen us rebrand as Primopus as we embark on the next chapter of the company. 2023 will be equally exciting as we continue to expand […]

Posted in News |

Primopus sets a sustainable course at the Senckenberg Natural History Museum Frankfurt.

Prof Katrin, Director of the Senckenberg Biodiversity and Climate Research Centre gave a very clear message on the importance of biodiversity in achieving a healthy world of the future. Pointing out the interconnectivity of climate, biodiversity and ecology it was clear that multiple species extinction was already happening for a lack of coordinated action worldwide. […]

Posted in News |

Encouraging Biodiversity

Primopus is organising a VIP event during CPHI Frankfurt, focused on preserving biodiversity and ecosystems at the Senckenberg Museum in Frankfurt. (Watch our brief video presentation below.) This event will be centred around a talk by Prof. Dr Katrin Bӧhning-Gaese, director of the Senckenberg Biodiversity and Climate Research Center. She won the German Environmental Award […]

Posted in News |

“Net Zero Carbon” by 2028 for our Basel, Switzerland CDMO plant

Primopus declares its goal of reaching net zero by working closely with its partner Getec Park.Swiss by 2028. In line with our new promise and purpose to ‘embrace exceptional life’, we are on the right path to source all our utilities and energy supply to make our production of RSM’s, GMP intermediates and API’s fully […]

Posted in News |